Danielle Bradshaw

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Top Venues

American journal of hematology

Hematology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Amany R Keruakous, Laura Walker, Molly Denlinger, Mohammad A H Mian, Danielle Bradshaw, Vamsi K Kota, Anand P Jillella
Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most? Hematology reports 16 (3) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Ibrahim Aldoss, Gregory W Roloff, Rawan G Faramand, Noam E Kopmar, Chenyu Lin, Anjali S Advani, Simone E Dekker, Vishal K Gupta, Timothy E O'Connor, Nikeshan Jeyakumar, Ibrahim N Muhsen, Yannis K Valtis, Amy Zhang, Katharine Miller, Katherine C Sutherland, Kaitlyn C Dykes, Mohamed Ahmed, Evan C Chen, Hector Zambrano, Danielle Bradshaw, Santiago Mercadal, Marc S Schwartz, Sean I Tracy, Bhagirathbhai R Dholaria, Michal Jakub Kubiak, Akash Mukherjee, Navneet S Majhail, Minoo Battiwalla, Luke Mountjoy, Shahbaz A Malik, John Mathews, Paul J Shaughnessy, Aaron C Logan, Abdullah Ladha, Maryann Stefan, Caitlin Guzowski, Rasmus T Hoeg, Talal Hilal, Jozal Moore, Matthew Connor, Kristen M O'Dwyer, LaQuisa C Hill, Stephanie B Tsai, Joshua P Sasine, Melhem M Solh, Catherine J Lee, Vamsi Kota, Divya Koura, Muthu Veeraputhiran, Betsy Blunk, Caspian Oliai, Jessica T Leonard, Noelle V Frey, Jae H Park, Marlise R Luskin, Veronika Bachanova, Ahmed Galal, Michael R Bishop, Wendy Stock, Ryan D Cassaday, Vinod A Pullarkat, Bijal D Shah, Lori S Muffly
Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood advances (2024)
Amany R Keruakous, Laura Walker, Molly Denlinger, Mohammad A H Mian, Danielle Bradshaw, Vamsi K Kota, Anand P Jillella
Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most? Hematology reports 16 (3) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology 99 (4) (2024)
Yasmin M Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie P Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers. American journal of hematology (2024)